MedPath

Mechanistische studie;Glycocalyx measurements in premature atherosclerosis.

Completed
Conditions
1. Glycocalyx
<br />2. Cardiovascular disease
<br />3. Atherosclerosis
<br />4. Premature atherosclerosis.
Registration Number
NL-OMON29486
Lead Sponsor
Academisch Ziekenhuis MaastrichtP. Debyelaan 25 6229 HX Maastricht Postadres: Postbus 5800 6202 AZ Maastricht Telefoon: 043 - 387 65 43 Fax: 043 - 387 78 78
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

Cases:

Subjects should have premature cardiovascular disease, which will be defined as:

Exclusion Criteria

Cases:

Patients will be excluded if they have a positive history for:
1. hypertension;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The systemic volume of the intravascular glycocalyx in subjects with premature atherosclerosis versus healthy control subjects.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath